Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Effect of proanthocyanidin single oral dose on glucose tolerance in response oral maltose load in healthy women

Saad Abdulrahman Hussain, Amal Ajaweed Sulaiman, Ameera Abdujabbar Aljamaly, Reyam Abdulrahman.




Abstract

Aim: The present study was designed to assess the effect of standardized proanthocyanidin on postprandial blood glucose level after maltose load in non diabetic females.
Materials and Methods: Single oral dose (50 mg) of proanthocyanidin tablet was administered by non diabetic adult females thirty minutes before oral ingestion of maltose load (50 gm) using acarbose as comparator. Blood glucose was monitored before and 15, 30, 60, 120, and 180 min post ingestion of maltose.
Results: The results showed considerable decrease in 30 and 60 min postprandial hyperglycemia due to the use of proanthocyanidin, while non significant decrease of AUC and delta AUC was obtained in both proanthocyanidin and acarbose groups compared with control. However, comparable results for 2 hr postprandial hyperglycemia were achieved by proanthocyanidin (41%) and acarbose (40%).
Conclusion: single oral dose of proanthocyanidin attenuates hyperglycemia after maltose challenge in non-diabetic females and such effect was comparable to that produced by acarbose.

Key words: proanthocyanidin, postprandial hyperglycemia, maltose load






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.